ArticleNPJ science of food2025
Digestion and fermentation of bionic grain-resistant corn starch and its effects on glucose response in mice.
Article in NPJ science of food, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
To address the rapid digestibility and nutritional imbalance of corn starch (CS), bionic grain-resistant corn starch embedded with gellan gum and soy protein isolate (CGS) was prepared by a co-encapsulation strategy to enhance enzymatic resistance and nutritional profile of CS. The proportion of resistant starch in cooked CGS increased from 9.3 to 22.6%. Structural characterization revealed that gellan gum formed a tight encapsulation structure with CS and soy protein isolate. Compared with CS, the CGS group in vitro fecal fermentation enhanced the yields of acetic, propionic, and butyric acids, and increased the abundance of Coprococcus comes, Bacteroides thetaiotaomicron, Prevotella copri, and Parabacteroides merdae by 17.6, 21.83, 3.17, and 6.68 times, respectively. Compared with CS, the CGS group exhibited a decrease in peak postprandial glucose from 11.98 to 9.58 mmol/L. This study offers a scientific foundation for creating starch-based foods to improve glucose metabolism disorders and promote intestinal health.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.